| |
Issentress Receives Traditional Approval from the FDA
|
| |
| |
On Jan.30, the U.S. Food and Drug Administration (FDA) granted traditional approval to ISENTRESS following review of the 48-week data from the BENCHMRK 1 & 2 clinical trials. The FDA previously granted accelerated approval for ISENTRESS in October 2007.
| |
| |
| |
|
|
|
